相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Flucytosine Antagonism of Azole Activity versus Candida glabrata: Role of Transcription Factor Pdr1 and Multidrug Transporter Cdr1
Zoe Steier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story
Nicola Baker et al.
TRENDS IN PARASITOLOGY (2013)
Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition
Pedro Cano-Soldado et al.
MEDICINAL RESEARCH REVIEWS (2012)
Widespread Genetic Switches and Toxicity Resistance Proteins for Fluoride
Jenny L. Baker et al.
SCIENCE (2012)
A two-step cloning-free PCR-based method for the deletion of genes in the opportunistic pathogenic yeast Candida lusitaniae
Sofiane El-Kirat-Chatel et al.
YEAST (2011)
Azole Drugs Are Imported By Facilitated Diffusion in Candida albicans and Other Pathogenic Fungi
Bryce E. Mansfield et al.
PLOS PATHOGENS (2010)
Nonsense and Missense Mutations in FCY2 and FCY1 Genes Are Responsible for Flucytosine Resistance and Flucytosine-Fluconazole Cross-Resistance in Clinical Isolates of Candida lusitaniae
Martine Florent et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Combination of different molecular mechanisms leading to fluconazole resistance in a Candida lusitaniae clinical isolate
David Reboutier et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Molecular mechanism of flucytosine resistance in Candida lusitaniae: Contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance
Nicolas Papon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans
Deming Xu et al.
PLOS PATHOGENS (2007)
Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to Flucytosine and Fluconazole in Candida lusitaniae
F Chapeland-Leclerc et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection marker
F François et al.
YEAST (2004)
Clade-specific flucytosine resistance is due to a single nucleotide change in the FURI gene of Candida albicans
AR Dodgson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn:: case report and review of the literature
A Favel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2003)
Metabolite-binding RNA domains are present in the genes of eukaryotes
N Sudarsan et al.
RNA (2003)
Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates:: Indirect evidence of a fluconazole uptake transporter
T Noël et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Candida lusitaniae infections in the era of fluconazole availability
JL Hawkins et al.
CLINICAL INFECTIOUS DISEASES (2003)
Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients
F François et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors
LM Podust et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
A Vermes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
分享论文
